Circle launches Arc blockchain to power the agentic economy with programmable real-time rails
Circle isn’t content just being the company behind the world’s second-largest stablecoin. It wants to build the financial plumbing for a future where AI agents buy, sell, and settle transactions without waiting for a human to click “approve.”
That’s the pitch behind Arc, Circle’s enterprise-grade Layer-1 blockchain designed to serve as what the company calls the “Economic OS for the internet.” CEO Jeremy Allaire has framed Arc as essential infrastructure for an agentic economy, one where autonomous software agents need programmable, real-time payment rails to function at scale.
What Arc actually does
The design priorities tell you everything about the intended user base: sub-second transaction finality, stablecoin-denominated gas fees starting with USDC, and embedded logic for policy enforcement and agent coordination.
Through what Circle calls “Nanopayments,” transaction fees can drop as low as $0.000001. For high-frequency, low-value machine-to-machine payments, those economics are essentially the difference between viable and not viable.
Arc’s public testnet went live on October 28, 2025, and attracted participation from over 100 companies.
Why this matters for Circle’s bigger picture
Circle went public on the NYSE under the ticker CRCL, and this move toward infrastructure is a significant expansion of its business model. For years, Circle’s story was relatively simple: issue USDC, earn yield on the reserves, repeat.
By denominating gas fees in USDC rather than a volatile native token, Arc sidesteps one of the more persistent complaints about blockchain transaction costs: that you never know what a transaction will actually cost because the fee token keeps moving.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tom Lee Says Yields Below 5% Mean the AI Selloff Is Nearly Over

Allergy and autoimmune biotechnology company Lycia Therapeutics (LYCA.US) will be listed on Nasdaq tonight! IPO priced at $18 per share, aiming to raise $317.5 millions.
Lycia will issue 17.64 million shares at a price of $18 per share to raise $317.5 million.
Citi is bullish on Palantir (PLTR.US): U.S. government and commercial businesses jointly drive growth, Q3 revenue is expected to exceed expectations again
Citigroup maintains its "Buy" rating on Palantir and raises the target price from $245 to $250.

Despite its stock price being halved, Goldman Sachs maintains a Buy rating: Holding $10 billions in orders, CoreWeave (CRWV) faces a major test with several billions in financing
As a core manufacturer of AI computing power infrastructure, CoreWeave (CRWV.US) holds orders worth tens of billions and its business is expanding rapidly. However, capital expenditure pressure and financing gaps have become the main concerns of the market.

